Boston · Massachusetts
Greater Boston device companies often begin with an invention licensed out of a hospital or university and grow up next to far larger competitors. Patent strategy here has to account for both facts from the first filing.
Greater Boston's medical technology sector is broad rather than concentrated in a single product category, and many of its largest participants are close neighbors. Boston Scientific and Hologic both maintain their headquarters in Marlborough, Insulet is based in Acton, and Abiomed, the Danvers company behind the Impella heart pump line, is now part of Johnson & Johnson. For a younger company, those same organizations are the likeliest future acquirers, licensees, partners, or adversaries.
A large share of new device concepts in the region begins inside institutions. Mass General Brigham Innovation manages licensing and intellectual property across a system that includes Massachusetts General Hospital, Brigham and Women's Hospital, Mass Eye and Ear, McLean Hospital, and Spaulding Rehabilitation. MIT's Technology Licensing Office licenses the Institute's patented inventions to established companies and startups, with considerable attention to biomedical and device technologies. Harvard's Wyss Institute works across Harvard schools and partner hospitals to translate biologically inspired materials and devices into products.
The surrounding support network is well organized. MassMEDIC, the Massachusetts Medical Device Industry Council, was founded in 1996 and offers mentoring and resources for emerging companies alongside its advocacy work. MassChallenge HealthTech, based in the Seaport, matches startups with clinical and corporate partners on challenges that include medical devices and wearables.
These conditions shape how a Boston-area portfolio should be assembled. When the core invention came from a hospital or university, investors and acquirers will ask whether the license actually covers the claims the product practices, whether clinician and faculty inventors met their obligations to the institution, and whether improvements made after formation belong to the company rather than the licensor. Physician co-inventors practicing at affiliated hospitals make careful inventorship analysis worth doing at filing, when facts are fresh. And because well-funded device companies operate nearby in overlapping areas, freedom-to-operate review before a design is locked usually costs far less than a redesign prompted by a demand letter.
Patent Strategy Considerations
Confirm that license grants, assignments, and field-of-use terms from the hospital or university cover what the product does today and what the roadmap adds. Gaps are much easier to cure before a financing than during one.
Physicians who contribute to a device may owe invention obligations to their hospital. Documenting each contributor's role at filing reduces later disputes over inventorship and ownership.
When established device companies hold portfolios in adjacent technology, a targeted freedom-to-operate review during design can identify claims worth designing around while changes are still inexpensive.
How Engagements Work
Knechtel Law Group is based in Carefree, Arizona. Patent prosecution and counseling before the U.S. Patent and Trademark Office is federal practice, and engagements with Boston-area companies are handled directly by senior counsel by video and in person as needed. Matters that turn on state law may call for local counsel.
Request a Confidential ConsultationCommon Questions
No. Practice before the USPTO is governed by federal rules, and a registered patent attorney may represent applicants wherever they are located in the United States. Knechtel Law Group is based in Carefree, Arizona. Questions governed by Massachusetts law, such as certain employment or corporate matters, or litigation in a particular court, may call for counsel admitted in that jurisdiction.
Start with the license itself: the licensed patents and applications, field of use, sublicensing rights, diligence milestones, and who controls prosecution. Then compare the licensed claims against the product as it is actually being built, since products often drift away from the original disclosure.
Typically once the design is concrete enough to compare against issued claims but before tooling, verification testing, and regulatory submissions lock it in. Updating the analysis before a financing or launch is also common.
Discuss Your Portfolio
Schedule a confidential consultation to discuss your technology, your existing portfolio, and your plans.
Request a Confidential Consultation